Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?

scientific article

Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9288771

P50authorGiske UrsinQ46387795
Leslie BernsteinQ60607806
Brian E. HendersonQ73660621
P2093author name stringHaile RW
Pike MC
Zhou N
Diep A
P433issue17
P407language of work or nameEnglishQ1860
P304page(s)3678-3681
P577publication date1997-09-01
P1433published inCancer ResearchQ326097
P1476titleDoes oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
P478volume57

Reverse relations

cites work (P2860)
Q85524852Across the Spectrum: Case Studies in Genetic Counseling for Breast and Ovarian Cancer
Q28387366BRCA1 and BRCA2 testing: weighing the demand against the benefits
Q46574954BRCA1 variants in a family study of African-American and Latina women
Q36983389Establishing a program for individuals at high risk for breast cancer
Q34077422Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis
Q35934068Hereditary ovarian cancer in Ashkenazi Jews
Q28384224Heritable breast cancer in twins
Q35794366Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study
Q92281866Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
Q36696565Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
Q24800615Oral contraceptive use before first birth and risk of breast cancer: a case control study
Q30433319Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study
Q35552356Ovarian cancer and high-risk women—implications for prevention, screening, and early detection
Q33923799Screening and clinical implications for BRCA1 and BRCA2 mutation carriers
Q35173107Screening women at increased risk with MRI
Q38456659The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study
Q90096220Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review

Search more.